* Clover Health Investments Corp CLOV.OQ reported a
quarterly
adjusted loss of 2 cents per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of -9 cents. The mean expectation of
three analysts for the quarter was for a loss of 4 cents per
share. Wall Street expected results to range from -5 cents to -3
cents per share.
* Revenue fell 31.3% to $330.99 million from a year ago;
analysts
expected $346.28 million.
* Clover Health Investments Corp's reported EPS for the
quarter
was a loss of 2 cents.
* The company reported a quarterly loss of $9.16 million.
* Clover Health Investments Corp shares had risen by 54.3%
this
quarter and gained 356.9% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 11.1%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the managed
healthcare
peer group is also "hold"
Wall Street's median 12-month price target for Clover Health
Investments Corp is $3.60
This summary was machine generated from LSEG data November 7 at
02:58 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.04 -0.02 Beat
Jun. 30 2024 -0.05 0.01 Beat
Mar. 31 2024 -0.07 -0.04 Beat
Dec. 31 2023 -0.14 -0.14 Met